Celine Kowalska

Celine Kowalska has worked at multiple companies in the field of scientific affairs and development. Celine started at The Binding Site Group Ltd as a Research Scientist in April 2005, specializing in protein purification from serum and plasma. Celine then joined Oncimmune in April 2006 as a Senior Scientist, where they worked until December 2011. In this role, they focused on scientific research. From December 2011 to September 2017, Celine served as a Principal Scientist at Oncimmune. Celine then progressed to the position of Associate Director and worked in this role until June 2021. From June 2021 to June 2022, they were the Head of Development and later became the Head of Scientific Affairs at Oncimmune.

Celine Kowalska's education history begins in 1996 when they attended the Classes Preparatoires Ecole d'Ingenieur BPCST, where they studied Biology, Physics, Chemistry, and Geology for three years. From 1999 to 2001, they pursued a Degree and Master in Biochemistry at the Université de Poitiers. Following that, they attended the University of Liverpool from 2001 to 2004, where they obtained a PhD in Molecular Biology applied to Organic Chemistry.

In addition to their academic qualifications, Celine Kowalska has also obtained additional certifications. In 2021, they completed the PRINCE2™ 2017 Foundation & Practitioner program offered by AXELOS Global Best Practice. In 2022, they completed the Women In Leadership Cat 4 – Level 7 programme at Nottingham Business School, Nottingham Trent University.